Jordan Matthew Dunitz MD
Critical Care Medicine, Cystic Fibrosis, Lung Transplantation Medicine, Pleural Disease
UMPhysicians
Join to View Full Profile
University of Minnesota Physicians516 Delaware Street SE PWB Second floor Clinic 2aMinneapolis, MN 55455
Phone+1 612-626-6100
Fax+1 612-625-2174
Dr. Dunitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994- University of MinnesotaResidency, Internal Medicine, 1988 - 1991
Stony Brook University Health Sciences Center School of MedicineClass of 1988
Certifications & Licensure
MN State Medical License 1993 - 2027
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Start of enrollment: 2013 Jun 01
- Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- Universal screening for hyperammonemia after lung transplantation: A retrospective cohort study of incidence and outcomes.Katherine D Wick, Jagadish Patil, Jordan Dunitz, JoAnne Billings, Sarah Kiel
JHLT Open. 2026-05-01 - 2 citationsHost- and microbial-mediated mucin degradation differentially shape Pseudomonas aeruginosa physiology and gene expression.Sabrina J Arif, Kayla M Hoffman, Jeffrey M Flynn, Talia D Wiggen, Sarah K Lucas
Plos Pathogens. 2025-10-01 - Personal narratives to support learning about lung transplant for people with cystic fibrosis.Dave Young, Lauren E Bartlett, Nick Reid, Andrea L Hartzler, Miranda C Bradford
Patient Education and Counseling. 2025-08-01
Press Mentions
New FDA-Approved Treatment for Cystic Fibrosis Gives Hope to ThousandsOctober 22nd, 2019
Grant Support
- A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-ControNational Center For Research Resources2009
- A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study Of VX-770 To EvalNational Center For Research Resources2008–2009
- 08-108: Denufosol Tetrasodium Inhalatoin Solution In Mild CF Lung DiseaseNational Center For Research Resources2007–2009
- A Phase 1, OPEN Label Safety And Tolerability Study Of Oral Theraclec In SubjectNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
